Cipla's global API revenue share 2019 by region

Cipla Limited earned about 32 percent of its global active pharmaceutical ingredients revenue from the emerging market regions, followed by 30 percent from the North American market.
Cipla has been increasingly partnering with leading generic companies for their new products in order to expand in markets such as Japan, China and others.

Share of global revenue from active pharmaceutical ingredients of Cipla Limited in financial year 2019, by region

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
in the first 12 months
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2019

Region

India

Survey time period

FY 2019

Supplementary notes

API refers to Active Pharmaceutical Ingredient.

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Italy"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.